NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 987 coverIMMUNE MECHANISMS AND DISEASE Copyright © 2003 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by ZHANG, Z.
Articles by COOPER, M. D.
Search for Related Content
PubMed
PubMed Citation
Articles by ZHANG, Z.
Articles by COOPER, M. D.
Annals of the New York Academy of Sciences 987:270-273 (2003)
© 2003 New York Academy of Sciences

Molecular Mechanism of Serial VH Gene Replacement

ZHIXIN ZHANGa, YUI-HSI WANGa, MICHAEL ZEMLINa, HARRY W. FINDLEYb, S. LOUIS BRIDGESc, PETER D. BURROWSa AND MAX D. COOPERa,d

aDivision of Developmental and Clinical Immunology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
bDivision of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Emory University School of Medicine, Atlanta, Georgia 30322, USA
cDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
dThe Howard Hughes Medical Institute, Birmingham, Alabama 35294, USA

Address for correspondence: Max D. Cooper, M.D., University of Alabama at Birmingham, WTI378, 1824 6th Avenue South, Birmingham, Alabama 35294-3300. Voice: 205-975-7204; fax: 205-934-1875.
max.cooper{at}ccc.uab.edu
Ann, N.Y. Acad. Sci. 987: 270-273 (2003).

The molecular mechanism of serial VH replacement was analyzed using a human B cell line, EU12, that undergoes continuous spontaneous differentiation from pro-B to pre-B and then to B cell stage. In earlier studies, we found that this cell line undergoes intraclonal V(D)J diversification. Analysis of the IgH gene sequences in EU12 cells predicted the occurrence of serial VH replacement involving the cryptic recombination signal sequences (cRSS) embedded within framework 3 regions and concurrent extension of the CDR3 region. Detection of double-stranded DNA breaks at the cRSS site and different VH replacement excision circles confirm the ongoing nature of this diversification process in the EU12 cells. In vitro binding and cleavage assays using recombinant RAG-1 and RAG-2 proteins further validated the cRSS participation in this RAG-mediated recombination process. Serial VH replacements may represent an additional mechanism for diversification of the primary B cell repertoire.

Key Words: molecular mechanism • serial VH replacement • Khuman B cell • VH gene • VL gene • double-stranded DNA




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Lutz, W. Muller, and H.-M. Jack
VH Replacement Rescues Progenitor B Cells with Two Nonproductive VDJ Alleles
J. Immunol., November 15, 2006; 177(10): 7007 - 7014.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. LIU, R. FAN, S. ZHOU, Z. YU, and Z. ZHANG
Potential Contribution of VH Gene Replacement in Immunity and Disease
Ann. N.Y. Acad. Sci., December 1, 2005; 1062(1): 175 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Jackson and J. D. Capra
IgH V-Region Sequence Does Not Predict the Survival Fate of Human Germinal Center B Cells
J. Immunol., March 1, 2005; 174(5): 2805 - 2813.
[Abstract] [Full Text] [PDF]



footerLeft footerRight